Renova Therapeutics | Finanzwire

Basculer en Français

9529	Companies
187436	Keywords
119464	Articles
100186	Press releases

Home
Companies
Renova Therapeutics

BRIEF

published on 06/12/2024 at 15:05, 1 year 6 months ago

Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions

Diabetes Clinical Trials Gene Therapy Renova Therapeutics Heart Failure
PRESS RELEASE

published on 06/12/2024 at 15:00, 1 year 6 months ago

Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions
Renova Therapeutics announces exploration of new therapeutic opportunities expanding gene therapy use for diabetes and heart failure. Clinical trials and preclinical studies show promising results

Diabetes Clinical Trials Gene Therapy Renova Therapeutics Heart Failure
BRIEF

published on 05/09/2024 at 03:05, 1 year 7 months ago

Renova Therapeutics Prioritizes Gene Therapy Development for Heart Failure and Type 2 Diabetes

Clinical Trials Gene Therapy Renova Therapeutics Heart Failure Treatment Type 2 Diabetes Treatment
PRESS RELEASE

published on 05/09/2024 at 03:00, 1 year 7 months ago

Renova Therapeutics Announces Strategic Focus and Roadmap Prioritization for Its Gene Therapies to Treat Heart Failure and Type 2 Diabetes Mellitus
Renova Therapeutics prioritizes two primary regulatory pathways for launching pivotal human trials of gene therapies to treat heart failure and type 2 diabetes mellitus

Clinical Trials Gene Therapy Renova Therapeutics Heart Failure Type 2 Diabetes Mellitus

Accesswire

Published on 12/15/2025 at 16:35, 56 minutes ago

Stillwater Critical Minerals Announces Upsize of Bought Deal LIFE Private Placement for Gross Proceeds of C$15 Million
Published on 12/15/2025 at 15:00, 2 hours 31 minutes ago

Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 2 hours 31 minutes ago

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 3 hours 1 minute ago

Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix
Published on 12/15/2025 at 14:00, 3 hours 31 minutes ago

Dateline Delivers Further High-Grade Intercepts from North Pipe at Colosseum

View all ACCESSWIRE

EQS Group

Published on 12/15/2025 at 17:15, 16 minutes ago

His Highness Sheikh Mansour bin Zayed Al Nahyan Launches "Al Khail Square" at Abu Dhabi Equestrian Club
Published on 12/15/2025 at 17:05, 26 minutes ago

Gensyn Launches $AI Token Sale on Sonar
Published on 12/15/2025 at 16:42, 49 minutes ago

EQS-Adhoc: Vitruvia Medical AG: successfull capital increase and strengthening of the financial structure
Published on 12/15/2025 at 16:08, 1 hour 23 minutes ago

Conversion of The Platform Group AG into a KGaA completed as planned
Published on 12/15/2025 at 15:50, 1 hour 40 minutes ago

Original-Research: Cabka N.V. (von First Berlin Equity Research GmbH): Kaufen

Les Echos

Published on 12/15/2025 at 11:50, 5 hours 41 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of November 30, 2025
Published on 12/12/2025 at 18:00, 2 days 23 hours ago

Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/12/2025 at 09:15, 3 days 8 hours ago

CHANGE IN THE SHARE CAPITAL
Published on 12/11/2025 at 19:23, 3 days 22 hours ago

Eiffage is joining the CAC 40 index
Published on 12/11/2025 at 08:30, 4 days 9 hours ago

Edenred and Daimler Truck join forces to accelerate the rollout of charging infrastructure for electric trucks in Europe

View all LES ECHOS COMFI WIRE